Navigation Links
Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding
Date:1/29/2008

OXFORD, England, January 29 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, announced today that it has successfully raised GBP11 million ($21.8 million) in an oversubscribed second round funding. The investment syndicate includes new investors Goldman Sachs and Invesco Perpetual, as well as existing investors, including Imperial Innovations and Lansdowne Partners.

"Completing this financing is a testament to the potential of Circassia's business, management and technology," said Steve Harris, Circassia's CEO. "We have made good progress advancing our anti-allergy products during the last year, and successfully completing this funding, particularly in the current challenging market conditions, is a strong vote of confidence from a syndicate of world-class investors."

Circassia, whose immune control technologies target allergies and organ rejection, completed an initial investment round of GBP6 million ($11.8 million) in January 2007. During the last year the company has finalised preparations to complete the phase II clinical testing programme for its lead product against cat dander allergy, and finalised the acquisition of its ToleroTrans organ anti-rejection technology. Following this second investment round, Circassia has increased its current cash balance to GBP15 million ($29.8 million), and plans to utilise the funds both to progress its clinical development programmes and to acquire additional technologies that fit its specialty business model.

Circassia's products have the potential to address significant market opportunities. Currently, over 150 million people suffer from allergic rhinitis in the US and Europe, and existing treatments either provide symptomatic relief only or require lengthy specialist physician supervision over a period of many months due to potential serious, even life-threatening, adverse reactions. In contrast, Circassia's technology uses sm
'/>"/>

SOURCE Circassia Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Primera Biosystems Raises $21 Million in Series B Private Round
2. Cellectar, Inc. Raises $13 Million in Private Offering
3. Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
4. Anesiva Raises $45 Million in Common Stock Offering
5. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
6. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
9. VisEn Medical Raises $7 Million in Series B Financing
10. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
11. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Texas , Sept. 11, 2014 XBiotech ... high throughput filling machine that the Company says will ... The fully integrated system is designed to fill, stopper ... the manufacturing process. Additionally, the unit is said to ... scanning system to provide a high level of quality ...
(Date:9/11/2014)... 11, 2014 The Registration Committee ... is now open for Pittcon 2015, the world’s ... The event will be held March 8-12, 2015, ... Louisiana. , The discounted registration fee of ... after 2/20/2015). This affordable price includes unlimited week-long ...
(Date:9/11/2014)... Francisco, California (PRWEB) September 11, 2014 ... of software and IT systems that support clinical ... Annotation™ (GVA™) Service that now supports the interpretation ... resulting in a single, user-friendly report that contains ... been used toward cancer treatment planning and support ...
(Date:9/11/2014)... 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... that it intends to conduct a Private Placement ... funding its preclinical development activities and financial commitments ... The Company is proposing to complete a ... shares at a price of US$0.10 per Share, ...
Breaking Biology Technology:Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 3Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4
... Five exceptional oncology nurses out of nearly 2,400 ... | US Oncology for their dedication to their ... Oncology Nursing Award honors those nurses in the United ... determination in providing the highest quality oncology nursing care to ...
... 22, 2011 The founders of Oncobiologics, Inc. today ... services, will launch itself to the biopharmaceutical industry at ... held June 27-30 at the Walter E. Washington Convention ... by a group of leading scientists and engineers from ...
... features below 100 nanometres have numerous applications ranging ... Tecnalia participates in a intragated FP7 European Project ... on nanoimprinting techniques (NIL), as a core aspect ... benefits followed are cost reduction, simpler fabrication process ...
Cached Biology Technology:McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 2McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 3McKesson Specialty Care Solutions | US Oncology Honors Five Exceptional Oncology Nurses for Outstanding Work 4Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention 2
(Date:9/12/2014)... Melbourne researchers have discovered that cartilage plays an ... joints seen in rheumatoid arthritis, rather than being ... Tommy Liu, Professor Ian Wicks, Dr Kate Lawler, ... and Eliza Hall Institute made the discovery while ... controlling inflammation during rheumatoid arthritis. The study was ...
(Date:9/12/2014)... Washington , September 12, 2014 ... source covering leading sectors including biometrics and mobile tech, issues ... launch of Apple Pay, its new payment service. ... founder of the Secure Identity and Biometrics Association (SIBA) and ... NXTD ) a company that is introducing its own ...
(Date:9/11/2014)... deadly legacy of DDT, American peregrine falcons ( Falco ... biologists proposed to stop rearing young birds in captivity ... Doug Bell published models that year in ESA,s journal ... for the falcon in California, with and without direct ... that the birds would continue to recover without captive ...
Breaking Biology News(10 mins):No innocent bystander: Cartilage contributes to arthritis 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5Volunteer 'eyes on the skies' track peregrine falcon recovery in California 2Volunteer 'eyes on the skies' track peregrine falcon recovery in California 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 4Volunteer 'eyes on the skies' track peregrine falcon recovery in California 5
... in the fruitfly genome, Johns Hopkins scientists have identified those ... captured a global view of all the genes turned on ... to be published April 3 in Developmental Cell, has implications ... move similarly to spread beyond an original tumor, which are ...
... Italy and Virginia Tech in the United States have ... for the production xanthurenic acid (XA) in Anopheles gambiae, ... in the sexual reproduction of the malaria parasite (Plasmodium ... of XA could be an avenue for development of ...
... from a new, five-year study show that regular use of ... cancer by up to 71 percent and may offer similar ... , The study findings were released today at the ... Washington, D.C. , "We believe this is the first ...
Cached Biology News:Researchers identify genes in fruitflies that may shed light on human cancer spread 2Oxidation defense in mosquitoes benefits malaria parasite 2COX-2 inhibitors significantly reduce risk of cancer 2
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
...
Biology Products: